Background Duodenal adenocarcinoma (DA) is a rare tumor for which survival data per
treatment modality and disease stage are unclear. This systematic review and meta-analysis …

Duodenal adenocarcinoma is a rare but aggressive malignancy. Given its rarity, previous
studies have traditionally combined duodenal adenocarcinoma (DA) with either other …

Objective This study was carried out to determine relative survival rates and trends in
outcomes in patients who underwent resection of periampullary adenocarcinomas (PACs) …

Background Duodenal adenocarcinoma is a rare cancer usually studied as a group with
periampullary or small bowel adenocarcinoma; therefore, its natural history is poorly …

Background Because duodenal adenocarcinoma (DA) is relatively rare, few studies have
investigated the impact of resection type on long-term outcomes. Methods The Surveillance …

Background Factors influencing long-term outcome after surgical resection for duodenal
adenocarcinoma are unclear. Methods A prospectively created database was reviewed for …

Small bowel adenocarcinoma (SBA) is a rare malignancy, with a rising incidence in recent
decades, and accounts for roughly 40% of all cancers of the small bowel. The majority of …

Extra-ampullary duodenal adenocarcinomas are rare, and when studied, frequently have
been grouped with jejunoileal adenocarcinomas. Nevertheless, anecdotal experiences …

Background The aim of our study was to compare the outcomes of periampullary and extra-
ampullary duodenal adenocarcinomas and segmental duodenal resection versus …

As primary duodenal adenocarcinoma is rare, the prognostic factors of this disease remain
insufficiently explored, especially in China. We identified postoperative duodenal …